John Anish M. 4
4 · Oncocyte Corp · Filed Aug 17, 2022
Insider Transaction Report
Form 4
John Anish M.
SVP, Finance, and Interim CFO
Transactions
- Award
Common Stock, no par value
2022-08-15+150,000→ 150,000 total - Award
Option to Purchase Common Stock
2022-08-15+100,000→ 100,000 totalExercise: $0.97Exp: 2032-08-15→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.
- [F2]25% of the options will become exercisable after one year of continuous service from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continuous service through the applicable vesting date.